Tower Research Capital LLC (Trc) Armata Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,005 shares of ARMP stock, worth $4,591. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,005
Previous 5,064
60.41%
Holding current value
$4,591
Previous $13,000
69.23%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$515,9070.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$245,1810.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$229,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$172,6240.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $82.8M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...